Selected research
Market Structure
Global Medications for Treating Alcohol Dependence Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medications for Treating Alcohol Dependence market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medications for Treating Alcohol Dependence include Teva, Sun Pharmaceutical Industries, Merck Group, Mylan, Zydus Pharmaceuticals, Glenmark Pharmaceuticals, Beijing Wellso Pharmaceutical Co, Taj Pharmaceuticals and TAGI Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Medications for Treating Alcohol Dependence market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medications for Treating Alcohol Dependence and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medications for Treating Alcohol Dependence revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medications for Treating Alcohol Dependence market size, projected growth trends, production technologies, key applications, and end-use industries.
Medications for Treating Alcohol Dependence Segment by Company
Teva
Sun Pharmaceutical Industries
Merck Group
Mylan
Zydus Pharmaceuticals
Glenmark Pharmaceuticals
Beijing Wellso Pharmaceutical Co
Taj Pharmaceuticals
TAGI Pharma Inc.
Rusan Pharma Ltd
Lundbeck
Alvogen
Alkermes Inc
Medications for Treating Alcohol Dependence Segment by Type
Disulfiram
Naltrexone
Acamprosate
Other
Medications for Treating Alcohol Dependence Segment by Application
Clinic
Hospital
Retail Pharmacies
Rehabilitation Institutions
Medications for Treating Alcohol Dependence Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Treating Alcohol Dependence market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medications for Treating Alcohol Dependence and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Treating Alcohol Dependence.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medications for Treating Alcohol Dependence in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medications for Treating Alcohol Dependence industry.
Chapter 3: Detailed analysis of Medications for Treating Alcohol Dependence companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medications for Treating Alcohol Dependencerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Disulfiram
- Naltrexone
- Acamprosate
- Other
Applications
- Clinic
- Hospital
- Retail Pharmacies
- Rehabilitation Institutions
Companies covered
- Teva
- Sun Pharmaceutical Industries
- Merck Group
- Mylan
- Zydus Pharmaceuticals
- Glenmark Pharmaceuticals
- Beijing Wellso Pharmaceutical Co
- Taj Pharmaceuticals
- TAGI Pharma Inc.
- Rusan Pharma Ltd
- Lundbeck
- Alvogen
- Alkermes Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Medications for Treating Alcohol Dependence Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Disulfiram
- 1.2.3 Naltrexone
- 1.2.4 Acamprosate
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Medications for Treating Alcohol Dependence Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Retail Pharmacies
- 1.3.5 Rehabilitation Institutions
- 1.4 Global Market Growth Prospects
- 1.5 Global Medications for Treating Alcohol Dependence Growth Trends by Region
- 1.5.1 Global Medications for Treating Alcohol Dependence Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Medications for Treating Alcohol Dependence Market Size by Region (2021-2026)
- 1.5.3 Medications for Treating Alcohol Dependence Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Medications for Treating Alcohol Dependence Market Dynamics
- 2.1 Medications for Treating Alcohol Dependence Industry Trends
- 2.2 Medications for Treating Alcohol Dependence Industry Drivers
- 2.3 Medications for Treating Alcohol Dependence Industry Opportunities and Challenges
- 2.4 Medications for Treating Alcohol Dependence Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Medications for Treating Alcohol Dependence Revenue by Company (2021-2026)
- 3.2 Global Medications for Treating Alcohol Dependence Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Medications for Treating Alcohol Dependence Key Company Head office and Area Served
- 3.4 Global Medications for Treating Alcohol Dependence Company, Product Type & Application
- 3.5 Global Medications for Treating Alcohol Dependence Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Medications for Treating Alcohol Dependence Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Medications for Treating Alcohol Dependence Players Market Share by Revenue in 2025
- 3.6.3 2025 Medications for Treating Alcohol Dependence Tier 1, Tier 2, and Tier 3
4 Medications for Treating Alcohol Dependence Market by Type
- 4.1 Global Medications for Treating Alcohol Dependence Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Medications for Treating Alcohol Dependence Market Size by Type (2021-2032)
- 4.3 Global Medications for Treating Alcohol Dependence Market Size Share by Type (2021-2032)
5 Medications for Treating Alcohol Dependence Market by Application
- 5.1 Global Medications for Treating Alcohol Dependence Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Medications for Treating Alcohol Dependence Market Size by Application (2021-2032)
- 5.3 Global Medications for Treating Alcohol Dependence Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Teva Medications for Treating Alcohol Dependence Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sun Pharmaceutical Industries
- 6.2.1 Sun Pharmaceutical Industries Company Information
- 6.2.2 Sun Pharmaceutical Industries Business Overview
- 6.2.3 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Product Portfolio
- 6.2.5 Sun Pharmaceutical Industries Recent Developments
- 6.3 Merck Group
- 6.3.1 Merck Group Company Information
- 6.3.2 Merck Group Business Overview
- 6.3.3 Merck Group Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Merck Group Medications for Treating Alcohol Dependence Product Portfolio
- 6.3.5 Merck Group Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Mylan Medications for Treating Alcohol Dependence Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Zydus Pharmaceuticals
- 6.5.1 Zydus Pharmaceuticals Company Information
- 6.5.2 Zydus Pharmaceuticals Business Overview
- 6.5.3 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
- 6.5.5 Zydus Pharmaceuticals Recent Developments
- 6.6 Glenmark Pharmaceuticals
- 6.6.1 Glenmark Pharmaceuticals Company Information
- 6.6.2 Glenmark Pharmaceuticals Business Overview
- 6.6.3 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
- 6.6.5 Glenmark Pharmaceuticals Recent Developments
- 6.7 Beijing Wellso Pharmaceutical Co
- 6.7.1 Beijing Wellso Pharmaceutical Co Company Information
- 6.7.2 Beijing Wellso Pharmaceutical Co Business Overview
- 6.7.3 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Product Portfolio
- 6.7.5 Beijing Wellso Pharmaceutical Co Recent Developments
- 6.8 Taj Pharmaceuticals
- 6.8.1 Taj Pharmaceuticals Company Information
- 6.8.2 Taj Pharmaceuticals Business Overview
- 6.8.3 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
- 6.8.5 Taj Pharmaceuticals Recent Developments
- 6.9 TAGI Pharma Inc.
- 6.9.1 TAGI Pharma Inc. Company Information
- 6.9.2 TAGI Pharma Inc. Business Overview
- 6.9.3 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Product Portfolio
- 6.9.5 TAGI Pharma Inc. Recent Developments
- 6.10 Rusan Pharma Ltd
- 6.10.1 Rusan Pharma Ltd Company Information
- 6.10.2 Rusan Pharma Ltd Business Overview
- 6.10.3 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Product Portfolio
- 6.10.5 Rusan Pharma Ltd Recent Developments
- 6.11 Lundbeck
- 6.11.1 Lundbeck Company Information
- 6.11.2 Lundbeck Business Overview
- 6.11.3 Lundbeck Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Lundbeck Medications for Treating Alcohol Dependence Product Portfolio
- 6.11.5 Lundbeck Recent Developments
- 6.12 Alvogen
- 6.12.1 Alvogen Company Information
- 6.12.2 Alvogen Business Overview
- 6.12.3 Alvogen Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Alvogen Medications for Treating Alcohol Dependence Product Portfolio
- 6.12.5 Alvogen Recent Developments
- 6.13 Alkermes Inc
- 6.13.1 Alkermes Inc Company Information
- 6.13.2 Alkermes Inc Business Overview
- 6.13.3 Alkermes Inc Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Alkermes Inc Medications for Treating Alcohol Dependence Product Portfolio
- 6.13.5 Alkermes Inc Recent Developments
7 North America
- 7.1 North America Medications for Treating Alcohol Dependence Market Size (2021-2032)
- 7.2 North America Medications for Treating Alcohol Dependence Market Size by Type
- 7.2.1 North America Medications for Treating Alcohol Dependence Market Size by Type (2021-2026)
- 7.2.2 North America Medications for Treating Alcohol Dependence Market Size by Type (2027-2032)
- 7.2.3 North America Medications for Treating Alcohol Dependence Market Share by Type (2021-2032)
- 7.3 North America Medications for Treating Alcohol Dependence Market Size by Application
- 7.3.1 North America Medications for Treating Alcohol Dependence Market Size by Application (2021-2026)
- 7.3.2 North America Medications for Treating Alcohol Dependence Market Size by Application (2027-2032)
- 7.3.3 North America Medications for Treating Alcohol Dependence Market Share by Application (2021-2032)
- 7.4 North America Medications for Treating Alcohol Dependence Market Size by Country
- 7.4.1 North America Medications for Treating Alcohol Dependence Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Medications for Treating Alcohol Dependence Market Size by Country (2021-2026)
- 7.4.3 North America Medications for Treating Alcohol Dependence Market Size by Country (2027-2032)
- 7.4.4 North America Medications for Treating Alcohol Dependence Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Medications for Treating Alcohol Dependence Market Size (2021-2032)
- 8.2 Europe Medications for Treating Alcohol Dependence Market Size by Type
- 8.2.1 Europe Medications for Treating Alcohol Dependence Market Size by Type (2021-2026)
- 8.2.2 Europe Medications for Treating Alcohol Dependence Market Size by Type (2027-2032)
- 8.2.3 Europe Medications for Treating Alcohol Dependence Market Share by Type (2021-2032)
- 8.3 Europe Medications for Treating Alcohol Dependence Market Size by Application
- 8.3.1 Europe Medications for Treating Alcohol Dependence Market Size by Application (2021-2026)
- 8.3.2 Europe Medications for Treating Alcohol Dependence Market Size by Application (2027-2032)
- 8.3.3 Europe Medications for Treating Alcohol Dependence Market Share by Application (2021-2032)
- 8.4 Europe Medications for Treating Alcohol Dependence Market Size by Country
- 8.4.1 Europe Medications for Treating Alcohol Dependence Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Medications for Treating Alcohol Dependence Market Size by Country (2021-2026)
- 8.4.3 Europe Medications for Treating Alcohol Dependence Market Size by Country (2027-2032)
- 8.4.4 Europe Medications for Treating Alcohol Dependence Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Medications for Treating Alcohol Dependence Market Size (2021-2032)
- 9.2 China Medications for Treating Alcohol Dependence Market Size by Type
- 9.2.1 China Medications for Treating Alcohol Dependence Market Size by Type (2021-2026)
- 9.2.2 China Medications for Treating Alcohol Dependence Market Size by Type (2027-2032)
- 9.2.3 China Medications for Treating Alcohol Dependence Market Share by Type (2021-2032)
- 9.3 China Medications for Treating Alcohol Dependence Market Size by Application
- 9.3.1 China Medications for Treating Alcohol Dependence Market Size by Application (2021-2026)
- 9.3.2 China Medications for Treating Alcohol Dependence Market Size by Application (2027-2032)
- 9.3.3 China Medications for Treating Alcohol Dependence Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Medications for Treating Alcohol Dependence Market Size (2021-2032)
- 10.2 Asia Medications for Treating Alcohol Dependence Market Size by Type
- 10.2.1 Asia Medications for Treating Alcohol Dependence Market Size by Type (2021-2026)
- 10.2.2 Asia Medications for Treating Alcohol Dependence Market Size by Type (2027-2032)
- 10.2.3 Asia Medications for Treating Alcohol Dependence Market Share by Type (2021-2032)
- 10.3 Asia Medications for Treating Alcohol Dependence Market Size by Application
- 10.3.1 Asia Medications for Treating Alcohol Dependence Market Size by Application (2021-2026)
- 10.3.2 Asia Medications for Treating Alcohol Dependence Market Size by Application (2027-2032)
- 10.3.3 Asia Medications for Treating Alcohol Dependence Market Share by Application (2021-2032)
- 10.4 Asia Medications for Treating Alcohol Dependence Market Size by Country
- 10.4.1 Asia Medications for Treating Alcohol Dependence Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Medications for Treating Alcohol Dependence Market Size by Country (2021-2026)
- 10.4.3 Asia Medications for Treating Alcohol Dependence Market Size by Country (2027-2032)
- 10.4.4 Asia Medications for Treating Alcohol Dependence Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Type
- 11.2.1 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Application
- 11.3.1 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Country
- 11.4.1 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Medications for Treating Alcohol Dependence Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst